Empagliflozin vs Rivaroxaban

Empagliflozin vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between Empagliflozin and Rivaroxaban.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Rivaroxaban: Direct Factor Xa inhibitor.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Rivaroxaban — 5-9 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Rivaroxaban — C19H18ClN3O5S.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Rivaroxaban — 435.8820 g/mol.

Type: Empagliflozin — Small molecule; Rivaroxaban — Small molecule.